Galmed Pharmaceuticals
GLMD
GLMD
38 hedge funds and large institutions have $103M invested in Galmed Pharmaceuticals in 2018 Q3 according to their latest regulatory filings, with 11 funds opening new positions, 7 increasing their positions, 7 reducing their positions, and 17 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding in top 10
Funds holding in top 10: →
more capital invested
Capital invested by funds: $ → $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less ownership
Funds ownership: →
14% less funds holding
Funds holding: 44 → 38 (-6)
35% less first-time investments, than exits
New positions opened: 11 | Existing positions closed: 17
100% less call options, than puts
Call options by funds: $0 | Put options by funds: $172K
Holders
38
Holding in Top 10
2
Calls
–
Puts
$172K
Top Buyers
| 1 | +$2.43M | |
| 2 | +$1.32M | |
| 3 | +$1.07M | |
| 4 |
RJA
Raymond James & Associates
St Petersburg,
Florida
|
+$984K |
| 5 |
VC
Vivo Capital
Palo Alto,
California
|
+$799K |
Top Sellers
| 1 | -$6.94M | |
| 2 | -$4.23M | |
| 3 | -$2.55M | |
| 4 |
Alyeska Investment Group
Chicago,
Illinois
|
-$2.08M |
| 5 |
First Manhattan
New York
|
-$1.55M |